Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Business Today
Zydus Cadila successfully completes phase 2 trials in COVID-19 patients using Hepatitis C treatment PegiHep

Zydus Cadila said its Pegylated Interferon alpha-2b, PegiHep, was originally approved for Hepatitis C and was launched in the Indian market in 2011


Brazilian medical institute Butantan said in a statement it would restart trials later on Wednesday

The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data

As coronavirus cases rise all over the world, Brazil continues to remain the third most affected country globally

Recently, Indian pharma companies are witnessing rampant cyber threats as they are delivering affordable medicines on a large scale amid the coronavirus pandemic